Pashupati Cotspin Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 10:54 pm

Competitors of Pashupati Cotspin Ltd

All Competitor Stocks of Pashupati Cotspin Ltd

Quarterly Result

Last Updated: August 20, 2025, 5:40 am

Below is a detailed analysis of the quarterly data for Pashupati Cotspin Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 106.08 Cr.. The value appears to be declining and may need further review. It has decreased from 127.47 Cr. (Mar 2025) to 106.08 Cr., marking a decrease of 21.39 Cr..
• For Expenses, as of Jun 2025, the value is 101.92 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 121.58 Cr. (Mar 2025) to 101.92 Cr., marking a decrease of 19.66 Cr..
• For Operating Profit, as of Jun 2025, the value is 4.16 Cr.. The value appears to be declining and may need further review. It has decreased from 5.89 Cr. (Mar 2025) to 4.16 Cr., marking a decrease of 1.73 Cr..
• For OPM %, as of Jun 2025, the value is 3.92%. The value appears to be declining and may need further review. It has decreased from 4.62% (Mar 2025) to 3.92%, marking a decrease of 0.70%.
• For Other Income, as of Jun 2025, the value is 4.11 Cr.. The value appears to be declining and may need further review. It has decreased from 8.37 Cr. (Mar 2025) to 4.11 Cr., marking a decrease of 4.26 Cr..
• For Interest, as of Jun 2025, the value is 3.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Mar 2025) to 3.29 Cr., marking an increase of 0.29 Cr..
• For Depreciation, as of Jun 2025, the value is 2.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.19 Cr. (Mar 2025) to 2.20 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.78 Cr.. The value appears to be declining and may need further review. It has decreased from 9.07 Cr. (Mar 2025) to 2.78 Cr., marking a decrease of 6.29 Cr..
• For Tax %, as of Jun 2025, the value is 26.98%. The value appears to be increasing, which may not be favorable. It has increased from 20.73% (Mar 2025) to 26.98%, marking an increase of 6.25%.
• For Net Profit, as of Jun 2025, the value is 2.03 Cr.. The value appears to be declining and may need further review. It has decreased from 7.19 Cr. (Mar 2025) to 2.03 Cr., marking a decrease of 5.16 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.29. The value appears to be declining and may need further review. It has decreased from 4.56 (Mar 2025) to 1.29, marking a decrease of 3.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:19 pm

Growth

Last Updated: September 5, 2025, 12:10 pm

Balance Sheet

Last Updated: August 11, 2025, 2:30 pm

Below is a detailed analysis of the balance sheet data for Pashupati Cotspin Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 139.00 Cr.. The value appears strong and on an upward trend. It has increased from 103.00 Cr. (Mar 2024) to 139.00 Cr., marking an increase of 36.00 Cr..
• For Borrowings, as of Mar 2025, the value is 99.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 151.00 Cr. (Mar 2024) to 99.00 Cr., marking a decrease of 52.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 30.00 Cr.. The value appears to be improving (decreasing). It has decreased from 41.00 Cr. (Mar 2024) to 30.00 Cr., marking a decrease of 11.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 284.00 Cr.. The value appears to be improving (decreasing). It has decreased from 310.00 Cr. (Mar 2024) to 284.00 Cr., marking a decrease of 26.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 127.00 Cr.. The value appears to be declining and may need further review. It has decreased from 135.00 Cr. (Mar 2024) to 127.00 Cr., marking a decrease of 8.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2024) to 36.00 Cr., marking a decrease of 7.00 Cr..
• For Other Assets, as of Mar 2025, the value is 121.00 Cr.. The value appears to be declining and may need further review. It has decreased from 132.00 Cr. (Mar 2024) to 121.00 Cr., marking a decrease of 11.00 Cr..
• For Total Assets, as of Mar 2025, the value is 284.00 Cr.. The value appears to be declining and may need further review. It has decreased from 310.00 Cr. (Mar 2024) to 284.00 Cr., marking a decrease of 26.00 Cr..

Notably, the Reserves (139.00 Cr.) exceed the Borrowings (99.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Pashupati Cotspin Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.31. This value is within the healthy range. It has increased from 5.43 (Mar 24) to 8.31, marking an increase of 2.88.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.31. This value is within the healthy range. It has increased from 5.43 (Mar 24) to 8.31, marking an increase of 2.88.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.96. This value is within the healthy range. It has increased from 13.17 (Mar 24) to 13.96, marking an increase of 0.79.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 97.78. It has increased from 77.57 (Mar 24) to 97.78, marking an increase of 20.21.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 97.78. It has increased from 77.57 (Mar 24) to 97.78, marking an increase of 20.21.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 403.88. It has decreased from 432.27 (Mar 24) to 403.88, marking a decrease of 28.39.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 25.03. This value is within the healthy range. It has decreased from 26.18 (Mar 24) to 25.03, marking a decrease of 1.15.
• For PBIT / Share (Rs.), as of Mar 25, the value is 19.23. This value is within the healthy range. It has increased from 18.45 (Mar 24) to 19.23, marking an increase of 0.78.
• For PBT / Share (Rs.), as of Mar 25, the value is 10.73. This value is within the healthy range. It has increased from 7.31 (Mar 24) to 10.73, marking an increase of 3.42.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.16. This value is within the healthy range. It has increased from 5.43 (Mar 24) to 8.16, marking an increase of 2.73.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.16. This value is within the healthy range. It has increased from 5.43 (Mar 24) to 8.16, marking an increase of 2.73.
• For PBDIT Margin (%), as of Mar 25, the value is 6.19. This value is below the healthy minimum of 10. It has increased from 6.05 (Mar 24) to 6.19, marking an increase of 0.14.
• For PBIT Margin (%), as of Mar 25, the value is 4.76. This value is below the healthy minimum of 10. It has increased from 4.26 (Mar 24) to 4.76, marking an increase of 0.50.
• For PBT Margin (%), as of Mar 25, the value is 2.65. This value is below the healthy minimum of 10. It has increased from 1.69 (Mar 24) to 2.65, marking an increase of 0.96.
• For Net Profit Margin (%), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 5. It has increased from 1.25 (Mar 24) to 2.02, marking an increase of 0.77.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 8. It has increased from 1.25 (Mar 24) to 2.02, marking an increase of 0.77.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.34. This value is below the healthy minimum of 15. It has increased from 7.00 (Mar 24) to 8.34, marking an increase of 1.34.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.49. This value is within the healthy range. It has decreased from 16.07 (Mar 24) to 15.49, marking a decrease of 0.58.
• For Return On Assets (%), as of Mar 25, the value is 4.30. This value is below the healthy minimum of 5. It has increased from 2.66 (Mar 24) to 4.30, marking an increase of 1.64.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 0.2. It has decreased from 0.38 (Mar 24) to 0.16, marking a decrease of 0.22.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.73. This value is within the healthy range. It has decreased from 1.27 (Mar 24) to 0.73, marking a decrease of 0.54.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.09. It has decreased from 2.13 (Mar 24) to 2.09, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has increased from 1.22 (Mar 24) to 1.57, marking an increase of 0.35.
• For Quick Ratio (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has increased from 0.91 (Mar 24) to 1.17, marking an increase of 0.26.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.85. This value is within the healthy range. It has decreased from 14.63 (Mar 24) to 7.85, marking a decrease of 6.78.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 13.80 (Mar 24) to 0.00, marking a decrease of 13.80.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.69 (Mar 24) to 0.00, marking a decrease of 5.69.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 86.20 (Mar 24) to 0.00, marking a decrease of 86.20.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.31 (Mar 24) to 0.00, marking a decrease of 94.31.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has increased from 2.35 (Mar 24) to 2.95, marking an increase of 0.60.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.96. This value is below the healthy minimum of 3. It has increased from 1.49 (Mar 24) to 1.96, marking an increase of 0.47.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,098.45. It has increased from 280.98 (Mar 24) to 1,098.45, marking an increase of 817.47.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has increased from 0.42 (Mar 24) to 1.72, marking an increase of 1.30.
• For EV / EBITDA (X), as of Mar 25, the value is 27.81. This value exceeds the healthy maximum of 15. It has increased from 7.02 (Mar 24) to 27.81, marking an increase of 20.79.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has increased from 0.19 (Mar 24) to 1.55, marking an increase of 1.36.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 86.19 (Mar 24) to 0.00, marking a decrease of 86.19.
• For Price / BV (X), as of Mar 25, the value is 6.39. This value exceeds the healthy maximum of 3. It has increased from 1.11 (Mar 24) to 6.39, marking an increase of 5.28.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has increased from 0.19 (Mar 24) to 1.55, marking an increase of 1.36.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.01, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness